Osteopathic Medicine in Fibromyalgia Syndrome (FIBROPATHIC)

August 29, 2025 updated by: Assistance Publique - Hôpitaux de Paris

A Multicenter, Randomized Study, Against Credible Factitious Intervention That Evaluates the Interest of Osteopathic Medicine in the Management of Fibromyalgia Syndrome

The purpose of this study is to evaluate the analgesic effects of a 6 weeks osteopathic treatment on patients with fibromyalgia.

Study Overview

Detailed Description

An osteopathic treatment could have a positive and durable effect on pain and quality of life on patients with fibromyalgia.

This technique, in addition to the standard treatment in a multidisciplinary care center, could be efficient by releasing muscle tension.

This is a 24 months multicenter (2 recruiting centers, 1 care center), randomized, and placebo-controlled study. The purpose is to evaluate the analgesic efficacy of a 6 weeks osteopathic treatment compared to a 6 week standard treatment on patients with fibromyalgia. It includes 6 osteopathic/standard sessions of 20 minutes (of one week apart), a follow-up at 3 months, 6 months and 12 months.

The primary aim of this study is to evaluate the pain after each osteopathic session, at the end of the 6 weeks treatment, and after each visit, judging by the patient's pain measured by a numeric scale (EVA).

The secondary aims of this study, based on clinical exams and questionnaires are to evaluate the quality of life, the patient activity and the sleep improvement after osteopathic treatment, and to investigate if osteopathic medicine improves fatigue, comorbidities, and decrease additional visits and medical investigations.

This study will also allow to identify the profile of the osteopathic treatment responders patients

Study Type

Interventional

Enrollment (Actual)

101

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Île-de-France Region
      • Paris, Île-de-France Region, France, 75004
        • Hotel-Dieu Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient Male or female aged at least of 18
  2. Patient with fibromyalgia, according to the American College of Rheumatology (ACR) 1990 criteria, with a global level of pain of 50 over a 100 mm EVA scale
  3. Patient suffering from fibromyalgia for over a year
  4. Patient with stable medical/non medical treatment for at least 1 month before the recruitment
  5. Patient referred to a medical center for a multidisciplinary approach
  6. Patient who can be followed for at least 12 months after the end of the osteopathic sessions
  7. Patient giving his informed consent to participate in the study
  8. Patient affiliated to or beneficiary of social insurance

Exclusion Criteria:

  1. Treatment by physical approach in progress or not older than 3 months : physiotherapy, kinesitherapy, rehabilitation or manual treatment (osteopathic or chiropractic care, manual medicine)
  2. Unability to attend 6 sessions, meaning one weekly session, of osteopathy, at Hôtel Dieu
  3. Severe psychiatric pathology : major depression, psychosis
  4. Pregnancy or breast feeding
  5. The patient is already included in another clinical study
  6. Patient under judicial protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Osteopathy +
75 patients will make 6 osteopathic sessions
osteopathic sessions of 20 minutes
Active Comparator: Osteopathy -
75 patients will make 6 factitious osteopathic sessions
6 factitious osteopathic sessions of 20 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of pain during the 6 weeks of osteopathic treatment
Time Frame: 6 weeks
The assessment will be on the declarative of the patient. He will report every week the intensity of pain measured by a numeric scale (0 to 100).
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 6 weeks after osteopathic treatment
Questionnaires: Fibromyalgia Impact Questionnaire (FIQ) and SF-36 (Short Form health survey)
6 weeks after osteopathic treatment
Quality of life
Time Frame: 3 months after osteopathic treatment
Questionnaires: FIQ and SF-36
3 months after osteopathic treatment
Quality of life
Time Frame: 6 months after osteopathic treatment
Questionnaires: FIQ and SF-36
6 months after osteopathic treatment
Quality of life
Time Frame: 1 year after osteopathic treatment
Questionnaires: FIQ and SF-36
1 year after osteopathic treatment
Fatigue
Time Frame: 6 weeks after osteopathic treatment
Questionnaires: multidimensional fatigue inventory (MFI) scale
6 weeks after osteopathic treatment
Fatigue
Time Frame: 3 months after osteopathic treatment
Questionnaires: MFI scale
3 months after osteopathic treatment
Fatigue
Time Frame: 6 months after osteopathic treatment
Questionnaires: MFI scale
6 months after osteopathic treatment
Fatigue
Time Frame: 1 year after osteopathic treatment
Questionnaires: MFI scale
1 year after osteopathic treatment
Pain
Time Frame: 6 weeks after osteopathic treatment
Questionnaires: Brief Pain Inventory (BPI)
6 weeks after osteopathic treatment
Pain
Time Frame: 3 months after osteopathic treatment
Questionnaires: BPI
3 months after osteopathic treatment
Pain
Time Frame: 6 months after osteopathic treatment
Questionnaires: BPI
6 months after osteopathic treatment
Pain
Time Frame: 1 year after osteopathic treatment
Questionnaires: BPI
1 year after osteopathic treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Serge PERROT, PU-PH, + 33 1.42.34.84.49

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2015

Primary Completion (Actual)

July 20, 2017

Study Completion (Actual)

July 27, 2018

Study Registration Dates

First Submitted

January 15, 2015

First Submitted That Met QC Criteria

January 15, 2015

First Posted (Estimated)

January 21, 2015

Study Record Updates

Last Update Posted (Estimated)

September 5, 2025

Last Update Submitted That Met QC Criteria

August 29, 2025

Last Verified

August 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia Syndrome

Clinical Trials on Osteopathic treatment

Subscribe